Notable Acquisitions in Health Diagnostics

, , ,
Integral service around a transaction
BY : Diego GutiérrezFebruary Wed, 2020

The health diagnostics sector includes all those companies dedicated to the development of techniques and instruments that facilitate the early diagnosis of pathologies and/or diseases and enable action to be taken against them as soon as possible.

Technological progress, the application of artificial intelligence in medicine and the rise of biotechnology have enabled strong growth in the sector. health diagnostics in recent years.

Since 2010, more than 1,500 companies have been created and around $13 billion in funding has been raised. Moreover, since 2018, growth has accelerated, raising almost $6 billion in some 300 funding rounds in just one year.

Notable acquisitions at Health Diagnostics

Health Diagnostics

Most recent investments

One of the most relevant operations of 2019 at the global level was that of Tangen Bioscienceswhich launched its second round (Round B) of fundraising for a total value of $75 million. Another important launch in 2019 was that of Zavathe medical and pharmaceutical services brand that raised $32 million in its first round (Round A). In addition, the company specialising in gut health Cara Care  raised $26.4 million in its second round of funding.

The most active investors in the A and B rounds in health diagnostics were the Novartis Venture Funds, F-Prime Capital and the Singaporean investment company Temasek Holdings.

The most active investors in the A and B rounds in health diagnostics have been the funds Novartis Venture, F- Prime Capital and Singaporean investment company Temasek Holdings.

Major acquisitions

One of the acquisitions The most significant acquisition in recent years was that of Envision Healthcare by the well-known US investment firm Kohlberg Kravis Roberts (KKR) for $750 million in June 2018.

The pharmaceutical company Roche acquired in February 2018 Flatiron Healtha company dedicated to the research and development of cancer solutions. 

The most important acquisition in 2019 was the acquisition of the pharmaceutical company Nightstar Therapeutics for Biogen. The deal was valued at $174.6 million.

The M&A Professionals

Meet our services



Do you want to be up to date?


Our diferentiation

Market Research Technology
Our team of market analysis specialists is continuously analyzing the investments of the most active markets in the industry in order to unceasingly contribute ideas of the current market situation and identify the most relevant trends for senior management. We integrate the most relevant sources of information which allows us to discover the most interesting companies for venture capital and similarly helps us to identify the investors with the highest probability of involvement in an M&A process to ensure the success of our sell-side operations.

The reports and deductions of our advisors provide a broad view of the sector, both geographically and from the complementary or adjacent markets perspective.
Technology Data Analytics
for M&A
Advanced data anlytics is a weapon". Intelfin is an artificial intelligence tool we use for investing and creating value in SMEs through competitive analytics and the enterprise environment.

IntelFin consists of a cognitive system, which, through the application of advanced analytical technologies, facilitates the automation of investment and financing decisions in the field of non-listed companies and especially SMEs in high-growth sectors.

The information related to these companies is characterized by their lack of transparency and heterogeneity; thus, it is necessary to develop an advanced analysis which is as much predictive as prescriptive and is developed in a natural language custom, suitable to obtain greater clarity and knowledge of the investment scope.

The IntelFin system focuses especially on analyzing the variables that define and influence the competitive environment of a sector and the positioning of a company, analyzing their influence on future value creation. Therefore, IntelFin supports strategic decision-making to senior management by resolving questions such as:

¿What are my competitors' priorities, strategies and expansion plans? Who's my competition? Which competitor is most likely to grow at a higher rate?
Which areas of activity/business models will receive the most investment? Which sectors are most attractive to investors?
Which companies are going to experience the most growth in the near future? Which companies are most likely to receive investment or be acquired?
Training Methodology
We have developed training programs in an innovative set-up which guarantees our teams the acquisition of technical competences both in the field of corporate finance and in the field of psychology, that is much needed when it comes to negotiation processes.

We have a culture of continuous improvement of our processes, closely related to the use of information systems that allow the enhancement of internal communication between our teams, as well as external communication with our customers. Hence, we extend best practices identified internally in an efficient and rapid manner among our members.

Are you one of those who prefer to be well informed when making decisions?